Open-label, randomized comparison trial of long-term outcomes of levofloxacin versus standard antibiotic therapy in acute exacerbations of chronic obstructive pulmonary disease-Reference-Cited by-同舟云学术

Open-label, randomized comparison trial of long-term outcomes of levofloxacin versus standard antibiotic therapy in acute exacerbations of chronic obstructive pulmonary disease

Published:2007-01 Issue:1 Volume:12 Page:117-121
ISSN:1323-7799
Container-title:Respirology
language:en
Short-container-title:Respirology

Author:

RUIZ-GONZÁLEZ Agustin,GIMÉNEZ Antonio,GÓMEZ-ARBONÉS Xavier,SOLER-GONZÁLEZ Jorge,SÁNCHEZ Virginia,FALGUERA Miquel,PORCEL Jose M.

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1440-1843.2006.00950.x/fullpdf

Reference24 articles.

1. Management of Acute Exacerbations of COPD

2. 2 R Pauwels, N Anthonisen, and WC Bailey et al.Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Update 2005.Available from URL: http://www.copdgold.com (accessed 12 October 2005).

3. The Evidence Base for Management of Acute Exacerbations of COPD

4. Worldwide Prevalence of Antimicrobial Resistance inStreptococcus pneumoniae, Haemophilus influenzae,andMoraxella catarrhalisin the SENTRY Antimicrobial Surveillance Program, 1997–1999

5. New Strains of Bacteria and Exacerbations of Chronic Obstructive Pulmonary Disease

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world antibiotic use in treating acute exacerbations of chronic obstructive pulmonary disease (AECOPD) in China: Evidence from the ACURE study;Frontiers in Pharmacology;2021-05-25

2. Does levofloxacin result in better outcomes than other antibiotics in treatment of COPD exacerbations?;Evidence-Based Practice;2020-04-21

3. Pharmacologic Therapies in Patients With Exacerbation of Chronic Obstructive Pulmonary Disease;Annals of Internal Medicine;2020-02-25

4. Acute exacerbations of COPD: risk factors for failure and relapse;International Journal of Chronic Obstructive Pulmonary Disease;2017-09

5. Levofloxacin: the role and significance in the treatment of lower respiratory tract infections;Clinical Medicine (Russian Journal);2017-01-10